Literature DB >> 35059117

The Inhibitors of Protein Tyrosine Phosphatase Nonreceptor Type 2 (PTPN2) as Potential Enhancers of Cancer Immunotherapy and Type 1 (PTPN1) as Treatment of Metabolic Diseases.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2021        PMID: 35059117      PMCID: PMC8762727          DOI: 10.1021/acsmedchemlett.1c00678

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

1.  CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis.

Authors:  Siddhartha Jaiswal; Catriona H M Jamieson; Wendy W Pang; Christopher Y Park; Mark P Chao; Ravindra Majeti; David Traver; Nico van Rooijen; Irving L Weissman
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

2.  In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target.

Authors:  Robert T Manguso; Hans W Pope; Margaret D Zimmer; Flavian D Brown; Kathleen B Yates; Brian C Miller; Natalie B Collins; Kevin Bi; Martin W LaFleur; Vikram R Juneja; Sarah A Weiss; Jennifer Lo; David E Fisher; Diana Miao; Eliezer Van Allen; David E Root; Arlene H Sharpe; John G Doench; W Nicholas Haining
Journal:  Nature       Date:  2017-07-19       Impact factor: 49.962

3.  Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer development.

Authors:  Egle Katkeviciute; Larissa Hering; Ana Montalban-Arques; Philipp Busenhart; Marlene Schwarzfischer; Roberto Manzini; Javier Conde; Kirstin Atrott; Silvia Lang; Gerhard Rogler; Elisabeth Naschberger; Vera S Schellerer; Michael Stürzl; Andreas Rickenbacher; Matthias Turina; Achim Weber; Sebastian Leibl; Gabriel E Leventhal; Mitchell Levesque; Onur Boyman; Michael Scharl; Marianne R Spalinger
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

  3 in total
  1 in total

Review 1.  Human Protein Tyrosine Phosphatase 1B (PTP1B): From Structure to Clinical Inhibitor Perspectives.

Authors:  Rongxing Liu; Cécile Mathieu; Jérémy Berthelet; Wenchao Zhang; Jean-Marie Dupret; Fernando Rodrigues Lima
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.